Oncology ImagingArchives
Machine learning-based MRI imaging for prostate cancer diagnosis: systematic review and meta-analysis
Oncology Imaging 3 min.
Prostate cancer has become the second most common malignancy and the fifth leading cause of cancer-related death among men globally, with nearly 1.4 million new cases and 375,000 deaths annually [1]. In Western countries, the incidence of prostate cancer is higher due to early screening using prostate-specific...
Predicting side-specific extraprostatic extension in prostate cancer using an 18F-DCFPyL PSMA-PET/CT–based nomogram
Oncology Imaging 4 min.
Extraprostatic extension (EPE) of the primary prostate cancer (PCa) lesion is indicative of aggressive disease. It remains an independent predictor of biochemical recurrence (BCR), progression-free survival, and need for adjuvant therapy [1, 2]. Furthermore, EPE has direct implications during prostate...
Diagnostic value of ultrasound peritumoral viscoelasticity parameters in breast cancer: enhancing BI-RADS classification performance
Oncology Imaging 5 min.
Breast cancer remains the most prevalent malignancy and leading cause of cancer-related mortality among women globally, with the World Health Organization (WHO) underscoring early detection as a critical determinant for improving prognostic outcomes and survival rates [1]. The histological examination...
MRI-Based peritumoral radiomics for predicting recurrence risk in ER+/HER2- breast cancer
Oncology Imaging 5 min.
With 2.3 million new cases occurring in 2020, breast cancer is the most common cancer worldwide [1], and rational treatment can help reduce recurrence and improve prognosis [2]. With the development of molecular techniques, breast cancer has been shown to be a highly heterogeneous tumor [3], which poses...
Tumor heterogeneity index from DCE-MRI for AKT-inhibition responder identification and reveals hot immune microenvironment for patients with breast cancer: a multi-omics analysis of I-SPY2 trial
Oncology Imaging 7 min.
The AKT/mammalian target of rapamycin (mTOR)/phosphatidylinositol-3-kinase (PI3K) signaling pathway plays a crucial role in the development, survival, and proliferation of tumor cells [1]. As a central component of the AKT/mTOR/PI3K pathway, AKT serves as an essential mediator that transmits signals...
